Skip to main content

Advertisement

SpringerLink
Log in

Helicobacter pylori seropositivity in fibromyalgia syndrome

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Although there are some studies suggesting relation between different types of infection and fibromyalgia syndrome (FM), there is presently no proof that FM is caused by an infection. Helicobacter pylori (HP) infection may cause extragastric manifestations. Inflammation is an important mediator of increased sympathetic nervous system activity and may lead to pain in fibromyalgia patients. In this study, we aimed to investigate the HP seropositivity in fibromyalgia patients compared with controls for possible role of HP infection in FM. Sixty-seven patients with fibromyalgia were evaluated. Two of them were excluded from the study because of high level of acute phase reactants. Sixty-five female patients with fibromyalgia and 41 randomly selected age-matched female healthy controls were enrolled to study. Serum HP IgA and IgG antibodies were measured by enzyme-linked immunosorbent assay technique. Fibromyalgia Impact Questionnaire was assessed in patients and controls. Seropositivity of HP IgG antibody in the fibromyalgia patients was significantly higher than in the control group. No statistically significant differences were found regarding the clinical features between fibromyalgia patients with HP IgG antibody and patients without IgG antibody. Our study suggests that former HP infection may have a role in the etiopathogenesis of fibromyalgia syndrome or may act as a triggering factor. However, high seroprevalence of HP in general population and prevalent asymptomatic infection make it difficult to interpret these results for the definite role of HP in FM. Highlighting the pathophysiologic mechanisms of FM will result in more effective treatment regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yunus MB, Inanici F (2002) Fibromyalgia syndrome: clinical features, diagnosis, and biopathophysiologic mechanisms. In: Rachlin ES, Rachlin IS (eds) Myofascial pain and Fibromyalgia. Mosby, Missouri, pp 3–31

    Chapter  Google Scholar 

  2. Neuman L, Buskila D (2003) Epidemiology of fibromyalgia. Curr Pain Headache Rep 7:362–368

    Article  Google Scholar 

  3. Wolfe F, Symthe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arth Rheum 33:160–172

    Article  CAS  Google Scholar 

  4. Bradley LA, Alarcon GS (1997) Fibromyalgia. Arthritis and allied conditions. A textbook of rheumatology. Williams and Wilkins, Baltimore, pp 1619–1640

    Google Scholar 

  5. Bennett RM (1993) Fibromyalgia and the facts. Sense or nonsense. Rheum Dis Clin North Am 19:45–59

    CAS  PubMed  Google Scholar 

  6. Ablin JN, Shoenfeld Y, Buskila D (2006) Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 27:145–152

    Article  PubMed  Google Scholar 

  7. Weibel RE, Benor DE (1996) Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the national vaccine injury compensation program. Arth Rheum 39:1529–1534

    Article  CAS  Google Scholar 

  8. Goldenberg DL (1993) Do infections trigger fibromyalgia. Arth Rheum 36:1489–1492

    Article  CAS  Google Scholar 

  9. Akhiani AA (2005) The role of type-spesific antibodies in colonization and infection by Helicobacter pylori. Curr Opin Infect Dis 18(3):223–227

    Article  CAS  PubMed  Google Scholar 

  10. de Korwin JD (2008) Does Helicobacter pylori infection play a role in extragastric diseases? Presse Med 37:525–534

    Article  PubMed  Google Scholar 

  11. Amital H, Govoni M, Maya R et al (2008) Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol 26(1):27–32

    Google Scholar 

  12. Buskila D, Gladman DD, Langevitz P et al (1990) Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 17:1202–1206

    CAS  PubMed  Google Scholar 

  13. Simms RW, Zerbini CA, Ferrante N et al (1992) Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med 92:368–374

    Article  CAS  PubMed  Google Scholar 

  14. Nash P, Chard M, Hazleman B (1989) Chronic coxsackie B infection mimicking primary fibromyalgia. J Rheumatol 16:1506–1508

    CAS  PubMed  Google Scholar 

  15. Berg AM, Naides SJ, Simms RW (1993) Established fibromyalgia and parvovirus B19 infection. J Rheumatol 20:1941–1943

    CAS  PubMed  Google Scholar 

  16. Leventhal LJ, Naides SJ, Freundlich B (1991) Fibromyalgia and parvovirus infection. Arthritis Rheum 34:1319–1324

    Article  CAS  PubMed  Google Scholar 

  17. Adak B, Tekeoglu I, Ediz L et al (2005) Fibromyalgia frequency in hepatitis B carriers. J Clin Rheumatol 11:157–159

    Article  PubMed  Google Scholar 

  18. Rivera J, de Diego A, Trinchet M et al (1997) Fibromyalgia associated hepatitis C virus infection. Br J Rheumatol 36:981–985

    Article  CAS  PubMed  Google Scholar 

  19. Kozanoglu E, Canataroglu A, Abayli B et al (2003) Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int 23:248–251

    Article  PubMed  Google Scholar 

  20. Buskila D, Shnaider A, Neumann L et al (1997) Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 157:2497–2500

    Article  CAS  PubMed  Google Scholar 

  21. Buchwald D, Goldenberg DL, Sullivan JL et al (1987) The “chronic, active Epstein-Barr virus infection” syndrome and primary fibromyalgia. Arth Rheum 30:1132–1136

    Article  CAS  Google Scholar 

  22. Wittrup IH, Jensen B, Bliddal H et al (2001) Comparison of viral antibodies in 2 groups of patients with fibromyalgia. J Rheumatol 28:601–603

    CAS  PubMed  Google Scholar 

  23. Dinerman H, Steere AC (1992) Lyme disease associated with fibromyalgia. Ann Intern Med 117:281–285

    CAS  PubMed  Google Scholar 

  24. Malt EA, Olafsson S, Ursin H (2004) Fibromyalgia a manifestation of Helicobacter pylori infection? Scan J of Rheum 33(2):131

    Article  Google Scholar 

  25. Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(5):154–162

    Google Scholar 

  26. Bennett RM, Kamin M, Karim R et al (2003) Tramadol and acetominophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med 114:537–545

    Article  CAS  PubMed  Google Scholar 

  27. Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5):728–733

    CAS  PubMed  Google Scholar 

  28. Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20(1):9–12

    Article  CAS  PubMed  Google Scholar 

  29. Demitrack MA (1998) Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management. Psychiatr Clin North Am 21(3):671–692

    Article  CAS  PubMed  Google Scholar 

  30. van West D, Maes M (2001) Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 15(8):521–531

    Article  PubMed  Google Scholar 

  31. Gur A, Oktayoglu P (2008) Status of immune mediators in fibromyalgia. Curr Pain Headache Rep 12(3):175–181

    Article  PubMed  Google Scholar 

  32. Yunus MB, Masi AT, Aldag JC (1989) A conrolled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol Suppl 19:62–71

    CAS  PubMed  Google Scholar 

  33. Büyükköse M, Kozanoğlu E, Basaran S et al (2009) Seroprevelance of parvovirus B19 in fibromyalgia syndrome. Clin Rheumatol 28:305–309

    Article  PubMed  Google Scholar 

  34. Öztürk C, Sahim G, Bagıs S et al (2002) Serological findings in fibromyalgia and non-specific pain syndromes: does parvovirus B-19 play a role? Turkiye Klinikleri J Med Sci 20:1–4

    Google Scholar 

  35. Buskila D, Shnaider A, Neumann L et al (1997) Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 157(21):2497–2500

    Article  CAS  PubMed  Google Scholar 

  36. Prelipcean CC, Mihai C, Gogalniceanu P et al (2007) Extragastric manifestations of Helicobacter pylori infection. Rev Med Chir Soc Med Nat Iasi 111(3):575–583

    PubMed  Google Scholar 

  37. Us D, Hascelik G (1998) Seroprevalence of Helicobacter pylori infection in an asymptomatic Turkish population. J Infect 37(2):148–150

    Article  CAS  PubMed  Google Scholar 

  38. Ustun Y, Engin-Ustun Y, Ozkaplan E et al (2009) Association of Helicobacter pylori infection with systemic inflammation in preeclampsia. J Matern Fetal Neonatal Med 28:1–4

    Article  Google Scholar 

  39. Monteiro L, de Mascarel A, Sarrasqueta AM et al (2001) Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol 96(2):353–358

    Article  CAS  PubMed  Google Scholar 

  40. Dunn BE, Cohen H, Blaser MJ (1997) Helicobacter pylori. Clin Microbiol Rev 10:720–741

    CAS  PubMed  Google Scholar 

  41. Jevremovic D, Torbenson M, Murray JA et al (2006) Atrophic autoimmune pangastritis: a distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am J Surg Pathol 30(11):1412–1419

    Article  PubMed  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Department of Physical Medicine and Rehabilitation, Pamukkale University Medical School, 20210, Kinikli, Denizli, Turkey

    Nuray Akkaya & Fusun Sahin

  2. Department of Orthopedics and Traumatology, Pamukkale University Medical School, 20210, Kinikli, Denizli, Turkey

    Semih Akkaya

  3. Clinical Microbiology, Denizli Government Hospital, Bayramyeri, Denizli, Turkey

    Yusuf Polat

  4. Clinical Parasitology, Denizli Government Hospital, Bayramyeri, Denizli, Turkey

    Meral Turk

  5. Clinic of Rheumatology, Denizli Government Hospital, Bayramyeri, Denizli, Turkey

    Tufan Turk

  6. Department of Public Health, Pamukkale University Medical School, Kinikli, Denizli, Turkey

    Elif Turhal

Authors
  1. Nuray Akkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Semih Akkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuf Polat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meral Turk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tufan Turk
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elif Turhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fusun Sahin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuray Akkaya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akkaya, N., Akkaya, S., Polat, Y. et al. Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol 30, 43–49 (2011). https://doi.org/10.1007/s10067-010-1618-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1618-9

Keywords

Search

Navigation